Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

whytestocks Free

11/03/20 6:15 PM

Post #7

BREAKING NEWS: $OXFD Oxford Immunotec Global PLC (OXFD) Q3 2020 Earnings Call Transcript

Image source: The Motley Fool. Oxford Immunotec Global PLC (NASDAQ: OXFD) Q3 2020 Earnings Call Nov 3, 2020 , 8:00 a.m. ET Operator Continue reading For further details see: Oxford Immunotec Global PLC (OXFD) Q3 2020 Earnings Call Transcr...

Read the whole news OXFD - Oxford Immunotec Global PLC (OXFD) Q3 2020 Earnings Call Transcript

whytestocks Free

11/03/20 6:00 PM

Post #6

JUST IN: $OXFD Oxford Immunotec Reports Third Quarter 2020 Financial Results

Third quarter revenue of $ 19.4 million, above guidance of range of $18 - $ 19 million Asia-Pacific region returns to g r owth and sets a new quarterly sales record for the region Europe & rest of world and U.S....

Find out more OXFD - Oxford Immunotec Reports Third Quarter 2020 Financial Results

whytestocks Free

08/06/19 11:10 AM

Post #5

News: $OXFD Oxford Immunotec Reports Second Quarter 2019 Financial Results

Second quarter revenue of $19.6 million, an increase of 18% compared to prior year period Gross margin of 72.4%, reflecting our shift towards a pure-play kit business Positive net income of $0.6 million compared to a net loss of $6.5 million in prior year period OXFORD, United K...

Read the whole news Oxford Immunotec Reports Second Quarter 2019 Financial Results

Chag

09/25/18 11:58 AM

Post #3

Darn I missed buying in this company. Been watching for years.

Avispa

08/15/17 9:17 AM

Post #2

Oxford Immunotec prices stock offering at $16.05

Aug. 15, 2017 9:13 AM ET|About: Oxford Immunotec Globa... (OXFD)|By: Douglas W. House, SA News Editor

•Oxford Immunotec (NASDAQ:OXFD) prices its public offering of 2.5M ordinary shares at $16.05 per share yielding gross proceeds of $40.125M. Underwriters over-allotment is an additional 375K shares. Closing date is August 18.

•Yesterday's close was $17.33.

•Now read: Omeros' OMS721 continues to demonstrate treatment benefit after one year in IgA nephropathy patients; shares ahead 5% »

https://seekingalpha.com/news/3289488-oxford-immunotec-prices-stock-offering-16_05